BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33145277)

  • 1. A pilot study of expanded newborn screening for 573 genes related to severe inherited disorders in China: results from 1,127 newborns.
    Luo X; Sun Y; Xu F; Guo J; Li L; Lin Z; Ye J; Gu X; Yu Y
    Ann Transl Med; 2020 Sep; 8(17):1058. PubMed ID: 33145277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing based newborn screening and comparative analysis with MS/MS.
    Shen G; Li W; Zhang Y; Chen L
    BMC Pediatr; 2024 Apr; 24(1):230. PubMed ID: 38561707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn Screening for Inborn Errors of Metabolism by Next-Generation Sequencing Combined with Tandem Mass Spectrometry.
    Tang C; Li L; Chen T; Li Y; Zhu B; Zhang Y; Yin Y; Liu X; Huang C; Miao J; Zhu B; Wang X; Zou H; Han L; Feng J; Huang Y
    Int J Neonatal Screen; 2024 Mar; 10(2):. PubMed ID: 38651393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates.
    Huang X; Wu D; Zhu L; Wang W; Yang R; Yang J; He Q; Zhu B; You Y; Xiao R; Zhao Z
    Orphanet J Rare Dis; 2022 Feb; 17(1):66. PubMed ID: 35193651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.
    Park KJ; Park S; Lee E; Park JH; Park JH; Park HD; Lee SY; Kim JW
    Ann Lab Med; 2016 Nov; 36(6):561-72. PubMed ID: 27578510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing as a second-tier diagnostic test for newborn screening.
    Luo X; Wang R; Fan Y; Gu X; Yu Y
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):927-931. PubMed ID: 30030962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded newborn screening for inherited metabolic disorders by tandem mass spectrometry in a northern Chinese population.
    Zhang H; Wang Y; Qiu Y; Zhang C
    Front Genet; 2022; 13():801447. PubMed ID: 36246604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.
    Maguolo A; Rodella G; Dianin A; Nurti R; Monge I; Rigotti E; Cantalupo G; Salviati L; Tucci S; Pellegrini F; Molinaro G; Lupi F; Tonin P; Pasini A; Campostrini N; Ion Popa F; Teofoli F; Vincenzi M; Camilot M; Piacentini G; Bordugo A
    Mol Genet Metab Rep; 2020 Sep; 24():100632. PubMed ID: 32793418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China.
    Yang RL; Qian GL; Wu DW; Miao JK; Yang X; Wu BQ; Yan YQ; Li HB; Mao XM; He J; Shen H; Zou H; Xue SY; Li XZ; Niu TT; Xiao R; Zhao ZY
    World J Pediatr; 2023 Jul; 19(7):663-673. PubMed ID: 36847978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
    Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
    Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening.
    Asamoah A; Wei S; Jackson KE; Hersh JH; Levy H
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34449521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population.
    Lin Y; Zheng Q; Zheng T; Zheng Z; Lin W; Fu Q
    Clin Chim Acta; 2019 Jul; 494():106-111. PubMed ID: 30904546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and molecular features of Thai patients with primary carnitine deficiency.
    Liammongkolkul S; Boonyawat B; Vijarnsorn C; Tim-Aroon T; Wasant P; Vatanavicharn N
    Pediatr Int; 2023 Jan; 65(1):e15404. PubMed ID: 36321377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards Next-Generation Sequencing (NGS)-Based Newborn Screening: A Technical Study to Prepare for the Challenges Ahead.
    Veldman A; Kiewiet MBG; Heiner-Fokkema MR; Nelen MR; Sinke RJ; Sikkema-Raddatz B; Voorhoeve E; Westra D; Dollé MET; Schielen PCJI; van Spronsen FJ
    Int J Neonatal Screen; 2022 Feb; 8(1):. PubMed ID: 35323196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum Analysis of Inherited Metabolic Disorders for Expanded Newborn Screening in a Central Chinese Population.
    Li X; He J; He L; Zeng Y; Huang X; Luo Y; Li Y
    Front Genet; 2021; 12():763222. PubMed ID: 35095998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn Genetic Screening Revealed Increased Levels of Biochemical Indicators in Carriers of Heterozygous Variants.
    Zhang W; Jin F; Guo R; Qi Z; Wang Y; Li X; Wu Y; Li W; Hu X; Hao C
    Genet Test Mol Biomarkers; 2022 Dec; 26(12):573-581. PubMed ID: 36577126
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal biochemical indicators of neonatal inherited metabolic disease in carriers.
    Guo F; Zhou L; Zhang F; Yu B; Yang Y; Liu Z
    Orphanet J Rare Dis; 2024 Apr; 19(1):145. PubMed ID: 38575986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of inherited metabolic disorders among newborns in Zhuzhou, a southern city in China.
    Luo H; Wang J; Chen J; Yi H; Yang X; Peng Y; Ni L; Yang YQ; Zhang XM; Huang H
    Front Genet; 2024; 15():1197151. PubMed ID: 38380423
    [No Abstract]   [Full Text] [Related]  

  • 20. Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis.
    Zhao Z; Chen C; Sun X; Zhou D; Huang X; Dong H
    J Med Screen; 2022 Mar; 29(1):12-20. PubMed ID: 34102920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.